Genetic characterization of HIV type 1 nef-induced vesicle secretion

AIDS Research and Human Retroviruses

Volumn 26, Issue 2, 2010, Pages 173-192

  Ali, Syed A ^a   Huang, Ming Bo ^a   Campbell, Patrick E ^a   Roth, William W ^a   Campbell, Tamika ^a   Khan, Mahfuz ^a   Newman, Gale ^a   Villinger, Francois ^b   Powell, Michael D ^a   Bond, Vincent C ^a  

^a MOREHOUSE SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEF PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; EXOSOME; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MYRISTYLATION; NONHUMAN; PHYLOGENY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SECRETORY VESICLE; SITE DIRECTED MUTAGENESIS; UBIQUITINATION;

AMINO ACID SEQUENCE; CELL LINE; GREEN FLUORESCENT PROTEINS; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; MUTANT PROTEINS; MUTATION; NEF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; PROTEIN SORTING SIGNALS; PROTEIN TRANSPORT; RECOMBINANT FUSION PROTEINS; TRANSFECTION; TRANSPORT VESICLES;

EID: 77149168513     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2009.0068     Document Type: Article

References (94)

1. Ho DD, Neumann AU, Perelson AS, et al.: Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995;373(6510):123-126.
2. Wei X, Ghosh SK, Taylor ME, et al.: Viral dynamics in human immunodeficiency virus type 1 infection. Nature 1995;373(6510):117-122.
3. Perelson AS, Neumann AU, Markowitz M, Leonard JM, and Ho DD: HIV-1 dynamics in vivo: Virion clearance rate, infected cell life-span, and viral generation time. Science 1996;271(5255):1582-1586.
4. Bagasra O, Hauptman SP, Lischner HW, Sachs M, and Pomerantz RJ: Detection of human immunodeficiency virus type 1 provirus in mononuclear cells by in situ polymerase chain reaction. N Engl J Med 1992;326(21):1385-1391.
5. Biberfeld P, Chayt KJ, Marselle LM, et al.: HTLV-III expression in infected lymph nodes and relevance to patho-genesis of lymphadenopathy. Am J Pathol 1986;125(3): 436-442.
6. Gratton S, Cheynier R, Dumaurier MJ, Oksenhendler E, and Wain-Hobson S: Highly restricted spread of HIV-1 and multiply infected cells within splenic germinal centers. Proc Natl Acad Sci USA 2000;97(26):14566-14571.
7. Simmonds P, Balfe P, Peutherer JF, et al.: Human immunodeficiency virus-infected individuals contain provirus in small numbers of peripheral mononuclear cells and at low copy numbers. J Virol 1990;64(2):864-872.
8. Mowat AM and Viney JL: The anatomical basis of intestinal immunity. Immunol Rev 1997;156:145-166.
9. Guadalupe M, Reay E, Sankaran S, et al.: Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. J Virol 2003;77(21):11708-11717.
10. Mehandru S, Poles MA, Tenner-Racz K, et al.: Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract. J Exp Med 2004;200(6):761-770.
11. Veazey RS, DeMaria M, Chalifoux LV, et al.: Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. Science 1998;280(5362):427-431.
12. Kewenig S, Schneider T, Hohloch K, et al.: Rapid mucosal CD4(+) T-cell depletion and enteropathy in simian immunodeficiency virus-infected rhesus macaques. Gastroenterology 1999;116(5):1115-1123.
13. Schneider T, Jahn HU, Schmidt W, et al.: Loss of CD4 T lymphocytes in patients infected with human immunodeficiency virus type 1 is more pronounced in the duodenal mucosa than in the peripheral blood. Berlin Diarrhea/Wasting Syndrome Study Group. Gut 1995;37(4):524-529.
14. Brenchley JM, Schacker TW, Ruff LE, et al.: CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med 2004; 200(6):749-759.
15. Clayton F, Snow G, Reka S, and Kotler DP: Selective depletion of rectal lamina propria rather than lymphoid aggregate CD4 lymphocytes in HIV infection. Clin Exp Immunol 1997;107(2):288-292.
16. Lim SG, Condez A, Lee CA, et al.: Loss of mucosal CD4 lymphocytes is an early feature of HIV infection. Clin Exp Immunol 1993;92(3):448-454.
17. Li Q, Duan L, Estes JD, et al.: Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells. Nature 2005;434(7037):1148-1152.
18. Badley AD, Dockrell D, Simpson M, et al.: Macrophage-dependent apoptosis of CD4+ T lymphocytes from HIV-infected individuals is mediated by FasL and tumor necrosis factor. J Exp Med 1997;185(1):55-64.
19. Berndt C, Mopps B, Angermuller S, Gierschik P, and Krammer PH: CXCR4 and CD4 mediate a rapid CD95-independent cell death in CD4(+) T cells. Proc Natl Acad Sci USA 1998;95(21):12556-12561.
20. Blanco J, Jacotot E, Cabrera C, et al.: The implication of the chemokine receptor CXCR4 in HIV-1 envelope protein-induced apoptosis is independent of the G protein-mediated signaling. AIDS 1999;13(8):909-917.
21. Carbonari M, Pesce AM, Cibati M, et al.: Death of bystander cells by a novel pathway involving early mitochondrial damage in human immunodeficiency virus-related lymph-adenopathy. Blood 1997;90(1):209-216.
22. Clerici M, Sarin A, Berzofsky JA, et al.: Antigen-stimulated apoptotic T-cell death in HIV infection is selective for CD4+ T cells, modulated by cytokines and effected by lymphotoxin. AIDS 1996;10(6):603-611.
23. Clerici M, Sarin A, Coffman RL, et al.: Type 1/type 2 cytokine modulation of T-cell programmed cell death as a model for human immunodeficiency virus pathogenesis. Proc Natl Acad Sci USA 1994;91(25):11811-11815.
24. Finkel TH, Tudor-Williams G, Banda NK, et al.: Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes [see comments]. Nat Med 1995;1(2):129-134.
25. Geleziunas R, Xu W, Takeda K, Ichijo H, and Greene WC: HIV-1 Nef inhibits ASK1-dependent death signalling providing a potential mechanism for protecting the infected host cell. Nature 2001;410(6830):834-838.
26. Gougeon ML, Lecoeur H, Dulioust A, et al.: Programmed cell death in peripheral lymphocytes from HIV-infected persons: Increased susceptibility to apoptosis of CD4 and CD8 T cells correlates with lymphocyte activation and with disease progression. J Immunol 1996;156(9):3509-3520.
27. Herbein G, Van Lint C, Lovett JL, and Verdin E: Distinct mechanisms trigger apoptosis in human immunodeficiency virus type 1-infected and in uninfected bystander T lymphocytes. J Virol 1998;72(1):660-670.
28. Ledru E, Lecoeur H, Garcia S, Debord T, and Gougeon ML: Differential susceptibility to activation-induced apoptosis among peripheral Th1 subsets: Correlation with Bcl-2 expression and consequences for AIDS pathogenesis. J Immunol 1998;160(7):3194-3206.
29. Miura Y, Misawa N, Maeda N, et al.: Critical contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to apoptosis of human CD4+ T cells in HIV-1-infected hu-PBL-NOD-SCID mice. J Exp Med 2001;193(5): 651-660.
30. Vlahakis SR, Algeciras-Schimnich A, Bou G, et al.: Chemokine-receptor activation by env determines the mechanism of death in HIV-infected and uninfected T lymphocytes. J Clin Invest 2001;107(2):207-215.
31. Chen H, Yip YK, George I, et al.: Chronically HIV-1-infected monocytic cells induce apoptosis in cocultured T cells. J Immunol 1998;161(8):4257-4267.
32. Jekle A, Keppler OT, De Clercq E, et al.: In vivo evolution of human immunodeficiency virus type 1 toward increased pathogenicity through CXCR4-mediated killing of uninfected CD4 T cells. J Virol 2003;77(10):5846-5854.
33. McCloskey TW, Ott M, Tribble E, et al.: Dual role of HIV Tat in regulation of apoptosis in T cells. J Immunol 1997; 158(2):1014-1019.
34. Zhang M, Li X, Pang X, et al.: Identification of a potential HIV-induced source of bystander-mediated apoptosis in T cells: Upregulation of trail in primary human macrophages by HIV-1 tat. J Biomed Sci 2001;8(3):290-296.
35. Kestler HW, III, Ringler DJ, Mori K, et al.: Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 1991;65(4):651-662.
36. Deacon NJ, Tsykin A, Solomon A, et al.: Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients [see comments]. Science 1995;270(5238):988-991.
37. Kirchhoff F, Greenough TC, Brettler DB, Sullivan JL, and Desrosiers RC: Brief report: Absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection [see comments]. N Engl J Med 1995;332(4):228-232.
38. Salvi R, Garbuglia AR, Di Caro A, et al.: Grossly defective nef gene sequences in a human immunodeficiency virus type 1-seropositive long-term nonprogressor. J Virol 1998; 72(5):3646-3657.
39. Learmont JC, Geczy AF, Mills J, et al.: Immunologic and virologic status after 14 to 18 years of infection with an attenuated strain of HIV-1. A report from the Sydney Blood Bank Cohort [see comments]. N Engl J Med 1999;340(22): 1715-1722.
40. Hanna Z, Kay DG, Rebai N, et al.: Nef harbors a major determinant of pathogenicity for an AIDS-like disease induced by HIV-1 in transgenic mice. Cell 1998;95(2):163-175.
41. Dickie P, Ramsdell F, Notkins AL, and Venkatesan S: Spontaneous and inducible epidermal hyperplasia in transgenic mice expressing HIV-1 Nef. Virology 1993;197(1):431-438.
42. Dickie P: HIV type 1 Nef perturbs eye lens development in transgenic mice. AIDS Res Hum Retroviruses 1996;12(3): 177-189.
43. Dickie P: Nef modulation of HIV type 1 gene expression and cytopathicity in tissues of HIV transgenic mice. AIDS Res Hum Retroviruses 2000;16(8):777-790.
44. Hanna Z, Weng X, Kay DG, et al.: The pathogenicity of human immunodeficiency virus (HIV) type 1 Nef in CD4C/HIV transgenic mice is abolished by mutation of its SH3-binding domain, and disease development is delayed in the absence of Hck. J Virol 2001;75(19):9378-9392.
45. Kajiyama W, Kopp JB, Marinos NJ, Klotman PE, and Dickie P: Glomerulosclerosis and viral gene expression in HIV-transgenic mice: role of nef. Kidney Int 2000;58(3):1148-1159.
46. Kay DG, Yue P, Hanna Z, et al.: Cardiac disease in transgenic mice expressing human immunodeficiency virus-1 nef in cells of the immune system. Am J Pathol 2002;161(1):321-335.
47. Simard MC, Chrobak P, Kay DG, et al.: Expression of simian immunodeficiency virus nef in immune cells of transgenic mice leads to a severe AIDS-like disease. J Virol 2002;76(8):3981-3995.
48. Skowronski J, Parks D, and Mariani R: Altered T cell activation and development in transgenic mice expressing the HIV-1 nef gene. EMBO J 1993;12(2):703-713.
49. Fujii Y, Otake K, Tashiro M, and Adachi A: In vitro cytocidal effects of human immunodeficiency virus type 1 Nef on unprimed human CD4+ T cells without MHC restriction. J Gen Virol 1996;77(Pt 12):2943-2951.
50. Fujii Y, Otake K, Tashiro M, and Adachi A: Human immunodeficiency virus type 1 Nef protein on the cell surface is cytocidal for human CD4+ T cells. FEBS Lett 1996;393(1): 105-108.
51. Fujii Y, Otake K, Tashiro M, and Adachi A: Soluble Nef antigen of HIV-1 is cytotoxic for human CD4+ T cells. FEBS Lett 1996;393(1):93-96.
52. Bouzar BA, Rea A, Hoc-Villet S, et al.: Activation/ proliferaferation and apoptosis of bystander goat lymphocytes induced by a macrophage-tropic chimeric caprine arthritis encephalitis virus expressing SIV Nef. Virology 2007;364(2): 269-280.
53. Homann S, Tibroni N, Baumann I, et al.: Determinants in HIV-1 Nef for enhancement of virus replication and depletion of CD4+ T lymphocytes in human lymphoid tissue ex vivo. Retrovirology 2009;6(1):6.
54. Huang MB, Jin LL, James CO, et al.: Characterization of Nef-CXCR4 interactions important for apoptosis induction. J Virol 2004;78(20):11084-11096.
55. James CO, Huang M-B, Khan M, et al.: Extracellular Nef protein targets CD4+ T cells for apoptosis by interacting with CXCR4 surface receptors. J Virol 2004;78(6):3099-3109.
56. Fujii Y, Otake K, Fujita Y, et al.: Clustered localization of oligomeric Nef protein of human immunodeficiency virus type 1 on the cell surface. FEBS Lett 1996;395(2-3):257-261.
57. Otake K, Fujii Y, Nakaya T, et al.: The carboxyl-terminal region of HIV-1 Nef protein is a cell surface domain that can interact with CD4+ T cells. J Immunol 1994;153(12):5826-5837.
58. Varin A, Manna SK, Quivy V, et al.: Exogenous Nef protein activates NF-kappa B, AP-1, and c-Jun N-terminal kinase and stimulates HIV transcription in promonocytic cells. Role in AIDS pathogenesis. J Biol Chem 2003;278(4):2219-2227.
59. Calenda V, Graber P, Delamarter JF, and Chermann JC: Involvement of HIV nef protein in abnormal hematopoiesis in AIDS: In vitro study on bone marrow progenitor cells. Eur J Haematol 1994;52(2):103-107.
60. Federico M, Percario Z, Olivetta E, et al.: HIV-1 Nef activates STAT1 in human monocytes/macrophages through the release of soluble factors. Blood 2001;98(9):2752-2761.
61. Percario Z, Olivetta E, Fiorucci G, et al.: Human immunodeficiency virus type 1 (HIV-1) Nef activates STAT3 in primary human monocyte/macrophages through the release of soluble factors: Involvement of Nef domains interacting with the cell endocytotic machinery. J Leukoc Biol 2003;74(5):821-832.
62. Annunziata P: Blood-brain barrier changes during invasion of the central nervous system by HIV-1. Old and new insights into the mechanism. J Neurol 2003;250(8):901-906.
63. Campbell TD, Khan M, Huang MB, Bond VC, and Powell MD: HIV-1 Nef protein is secreted into vesicles that can fuse with target cells and virions. Ethn Dis 2008;18(2 Suppl 2):S2-S9.
64. Guy B, Riviere Y, Dott K, Regnault A, and Kieny MP: Mutational analysis of the HIV nef protein. Virology 1990; 176(2):413-425.
65. Macreadie IG, Fernley R, Castelli LA, et al.: Expression of HIV-1 nef in yeast causes membrane perturbation and release of the myristylated Nef protein. J Biomed Sci 1998; 5(3):203-210.
66. Sanfridson A, Hester S, and Doyle C: Nef proteins encoded by human and simian immunodeficiency viruses induce the accumulation of endosomes and lysosomes in human T cells. Proc Natl Acad Sci USA 1997;94(3):873-878.
67. Stumptner-Cuvelette P, Jouve M, Helft J, et al.: Human immunodeficiency virus-1 Nef expression induces intracellular accumulation of multivesicular bodies and major histocom-patibility complex class II complexes: Potential role of phosphatidylinositol 3-kinase. Mol Biol Cell 2003;14(12): 4857-4870.
68. Esser MT, Graham DR, Coren LV, et al.: Differential incorporation of CD45, CD80 (B7-1), CD86 (B7-2), and major histocompatibility complex class I and II molecules into human immunodeficiency virus type 1 virions and micro-vesicles: Implications for viral pathogenesis and immune regulation. J Virol 2001;75(13):6173-6182.
69. Cantin R, Diou J, Belanger D, Tremblay AM, and Gilbert C: Discrimination between exosomes and HIV-1: Purification of both vesicles from cell-free supernatants. J Immunol Methods 2008;338(1-2):21-30.
70. Coren LV, Shatzer T, and Ott DE: CD45 immunoaffinity depletion of vesicles from Jurkat T cells demonstrates that "exosomes" contain CD45: No evidence for a distinct exosome/HIV-1 budding pathway. Retrovirology 2008;5(1): 64.
71. Huang MB, Hunter M, and Bond VC: Effect of extracellular human immunodeficiency virus type 1 glycoprotein 120 on primary human vascular endothelial cell cultures. AIDS Res Hum Retroviruses 1999;15(14):1265-1277.
72. Thery C, Boussac M, Veron P, et al.: Proteomic analysis of dendritic cell-derived exosomes: A secreted subcellular compartment distinct from apoptotic vesicles. J Immunol 2001;166(12):7309-7318.
73. Raposo G, Nijman HW, Stoorvogel W, et al.: B lymphocytes secrete antigen-presenting vesicles. J Exp Med 1996;183(3): 1161-1172.
74. Giese SI, Woerz I, Homann S, et al.: Specific and distinct determinants mediate membrane binding and lipid raft incorporation of HIV-1(SF2) Nef. Virology 2006;355:175-191.
75. Piguet V, Wan L, Borel C, et al.: HIV-1 Nef protein binds to the cellular protein PACS-1 to downregulate class I major histo-compatibility complexes. Nat Cell Biol 2000;2(3):163-167.
76. Wan L, Molloy SS, Thomas L, et al.: PACS-1 defines a novel gene family of cytosolic sorting proteins required for trans-Golgi network localization. Cell 1998;94(2):205-216.
77. Geyer M, Munte CE, Schorr J, Kellner R, and Kalbitzer HR: Structure of the anchor-domain of myristoylated and non-myristoylated HIV-1 Nef protein. J Mol Biol 1999;289(1):123-138.
78. Aupeix K, Hugel B, Martin T, et al.: The significance of shed membrane particles during programmed cell death in vitro, and in vivo, in HIV-1 infection. J Clin Invest 1997;99(7):1546-1554.
79. Fevrier B and Raposo G: Exosomes: Endosomal-derived vesicles shipping extracellular messages. Curr Opin Cell Biol 2004;16(4):415-421.
80. Johnstone RM, Bianchini A, and Teng K: Reticulocyte maturation and exosome release: Transferrin receptor containing exosomes shows multiple plasma membrane functions. Blood 1989;74(5):1844-1851.
81. Baldwin TA and Ostergaard HL: The protein-tyrosine phosphatase CD45 reaches the cell surface via Golgi-dependent and -independent pathways. J Biol Chem 2002; 277(52):50333-50340.
82. Garcia BA, Smalley DM, Cho H, et al.: The platelet micro-particle proteome. J Proteome Res 2005;4(5):1516-1521.
83. Meziani F, Tesse A, and Andriantsitohaina R: Microparticles are vectors of paradoxical information in vascular cells including the endothelium: Role in health and diseases. Pharmacol Rep 2008;60(1):75-84.
84. Geyer M, Fackler OT, and Peterlin BM: Structure-function relationships in HIV-1 Nef. EMBO Rep 2001;2(7):580-585.
85. Baur AS, Sawai ET, Dazin P, et al.: HIV-1 Nef leads to inhibition or activation of T cells depending on its intracellular localization. Immunity 1994;1(5):373-384.
86. Sawai ET, Baur AS, Peterlin BM, Levy JA, and Cheng-Mayer C: A conserved domain and membrane targeting of Nef from HIV and SIV are required for association with a cellular serine kinase activity. J Biol Chem 1995;270(25):15307-15314.
87. Bentham M, Mazaleyrat S, Harris M, et al.: Role of myristoylation and N-terminal basic residues in membrane association of the human immunodeficiency virus type 1 Nef protein. J Gen Virol 2006;87(Pt 3):563-571.
88. Fackler OT, Moris A, Tibroni N, et al.: Functional characterization of HIV-1 Nef mutants in the context of viral infection. Virology 2006;351(2):322-339.
89. Resh MD: Fatty acylation of proteins: New insights into membrane targeting of myristoylated and palmitoylated proteins. Biochim Biophys Acta 1999;1451(1):1-16.
90. Resh MD: Membrane targeting of lipid modified signal transduction proteins. Subcell Biochem 2004;37:217-232.
91. Welker R, Harris M, Cardel B, and Krausslich HG: Virion incorporation of human immunodeficiency virus type 1 Nef is mediated by a bipartite membrane-targeting signal: Analysis of its role in enhancement of viral infectivity. J Virol 1998;72(11):8833-8840.
92. Seaman MN: Endosome protein sorting: Motifs and machinery. Cell Mol Life Sci 2008;65(18):2842-2858.
93. Taylor DD, Akyol S, and Gercel-Taylor C: Pregnancy-associated exosomes and their modulation of T cell signaling. J Immunol 2006;176(3):1534-1542.
94. Yu S, Liu C, Su K, et al.: Tumor exosomes inhibit differentiation of bone marrow dendritic cells. J Immunol 2007; 178(11):6867-6875.